Jan Skvarka

Insider Reports History

Location
Mississauga, Ontario, Canada
Signature
/s/ Andrea Paul, attorney-in-fact for Jan Skvarka
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jan Skvarka:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. Director Common Stock 207,154 $267,228 $1.29 17 Jun 2025 Direct
Monte Rosa Therapeutics, Inc. Director Stock Option (Right to Buy) 30,700 13 Jun 2025 Direct
Trillium Therapeutics Inc. President and CEO, Director Common Shares 0 12 May 2021 Direct
Trillium Therapeutics Inc. President and CEO, Director Stock Option (Right to Buy) 0 17 Nov 2021 Direct

Insider Reports Filed by Jan Skvarka

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZNTL Zentalis Pharmaceuticals, Inc. 17 Jun 2025 1 $0 4 Director 18 Jun 2025, 16:17
GLUE Monte Rosa Therapeutics, Inc. 13 Jun 2025 1 $0 4 Director 16 Jun 2025, 16:05
ZNTL Zentalis Pharmaceuticals, Inc. 31 Jan 2025 1 +$103,446 4 Director 04 Feb 2025, 16:45
ZNTL Zentalis Pharmaceuticals, Inc. 21 Jun 2024 1 $0 4 Director 21 Jun 2024, 17:11
GLUE Monte Rosa Therapeutics, Inc. 12 Jun 2024 1 $0 4 Director 13 Jun 2024, 16:30
ZNTL Zentalis Pharmaceuticals, Inc. 11 Sep 2023 1 -$125,238 4 Director 13 Sep 2023, 17:11
ZNTL Zentalis Pharmaceuticals, Inc. 16 Jun 2023 1 $0 4 Director 16 Jun 2023, 17:01
GLUE Monte Rosa Therapeutics, Inc. 14 Jun 2023 1 $0 4 Director 15 Jun 2023, 16:29
GLUE Monte Rosa Therapeutics, Inc. 30 Mar 2023 1 $0 4 Director 31 Mar 2023, 16:15
GLUE Monte Rosa Therapeutics, Inc. 23 Mar 2023 0 $0 3 Director 24 Mar 2023, 16:15
ZNTL Zentalis Pharmaceuticals, Inc. 09 Sep 2022 1 $0 4 Director 12 Sep 2022, 07:07
ZNTL Zentalis Pharmaceuticals, Inc. 09 Sep 2022 0 $0 3 Director 12 Sep 2022, 07:06
/report/000110465921141737-skvarka-jan-2021-11-17 Trillium Therapeutics Inc. 17 Nov 2021 3 $0 4 President and CEO, Director 19 Nov 2021, 12:20
/report/000106299321004511-skvarka-jan-2021-05-11 Trillium Therapeutics Inc. 11 May 2021 8 -$1,149,139 4 President and CEO, Director 13 May 2021, 16:12